Skip to main content
OpenTrials
Completed

NCT Number: NCT05269199

Sexual Health Impact of Using Pre-exposure HIV Prophylaxis

Epidemiological and psychosociological survey of people on pre-exposure HIV prophylaxis (PrEP).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pre-exposure HIV Prophylaxis (PrEP)

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Primary location

CH Brioude, Brioude, France

Loading trial locations.

About this study

This study is perform to study the sexual health satisfaction of men who have sex with men (MSM), since the use pre-exposure HIV prophylaxis (PrEP), compared to the time before PrEP.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patient, male having sex with men, not infected with HIV, and using HIV prophylaxis by pre-exposure treatment (PrEP) for at least 1 year, received in consultation for renewal of this prescription.
  • Able to give his non-opposition to participate in the research.
  • Affiliation to a social security scheme.

Exclusion criteria

  • Patient under curatorship/guardianship or safeguard of justice
  • Refusal to participate

Treatment and study plan

Primary outcomes

  1. Sexual health satisfaction

    Time frame: 1 day during the scheduled consultation

    To study the sexual health satisfaction of men who have sex with men (MSM), since the use of HIV prophylaxis by pre-exposure treatment (PrEP), compared to the time before PrEP.

Secondary outcomes

  1. Sentimental satisfaction

    Time frame: 1 day during the scheduled consultation

    To study the sentimental satisfaction since the use of HIV prophylaxis by treatment before exposure (PrEP), compared to the time before PrEP.

  2. Risky behaviours

    Time frame: 1 day during the scheduled consultation

    To study risky behaviours without, then on PrEP since the use of HIV prophylaxis by treatment before exposure (PrEP), compared to the time before PrEP.

  3. Specific care

    Time frame: 1 day during the scheduled consultation

    Describe the use of specific care during PrEP.

  4. Predictors of satisfaction

    Time frame: 1 day during the scheduled consultation

    Define possible predictors of satisfaction with PrEP.

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Registry information

Acronym: SatisPreP

Important dates

Study start
2022
Primary completion
2022
Study completion
2023
First posted
Mar 7, 2022
Registry last updated
May 1, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.